The evolution of thrombin-fibrinogen-reactions
Söderqvist, T.
Nordisk Medicin 85(14): 433-434
1971
ISSN/ISBN: 0029-1420 PMID: 5574440 Document Number: 38653
Document emailed within 1 workday
Related Documents
Hoak, D.R.; Banerjee, S.K.; Kaldor, G. 1988: An automated approach to characterize, in simple kinetic terms, the generation and inactivation of thrombin and the interaction of fibrinogen with thrombin Clinical Chemistry 34(10): 1971-1975Forsberg, P.O. 1989: Dephosphorylation of human fibrinogen, previously phosphorylated in vitro by protein kinase C, by whole blood or intestinal alkaline phosphatase. Effects on thrombin-induced gelation of in vitro dephosphorylated human fibrinogen Thrombosis Research 53(1): 1-9
Merkulov, M.F.; Serbinenko, F.A.; Oseledko, W.D.; Padalko, P.I. 1974: The use of fibrinogen and thrombin for localized thrombosing of arteries Folia Haematologica 101(2): 313-316
Gaertner, H. 1971: Effect of erythrocytes and hemolysates on the thrombin and fibrinogen reaction Przeglad Lekarski 28(11): 692-694
Binnie, C.G.; Lord, S.T. 1991: A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin Thrombosis and Haemostasis 65(2): 165-168
Meh, D.A.; Siebenlist, K.R.; Bergtrom, G.; Mosesson, M.W. 1995: Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin Journal of Laboratory and Clinical Medicine 125(3): 384-391
Di Carlo, I.; Pulvirenti, E.; Toro, A. 2009: Use of a fibrinogen- and thrombin-coated patch for peptic ulcer perforation repair Hepato-Gastroenterology 56(91-92): 575-577
Momi, S.; Nasimi, M.; Colucci, M.; Nenci, G.G.; Gresele, P. 2001: Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition Haematologica 86(3): 297-302
Giansante, C.; Fiotti, N.; Cattin, L.; Da Col, P.G.; Calabrese, S. 1994: Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors Thrombosis and Haemostasis 71(5): 581-586
Sonder, S.A.; Fenton, J.W. 1986: Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities Clinical Chemistry 32(6): 934-937
Doolittle, R.F. 1976: The evolution of vertebrate fibrinogen Federation Proceedings 35(10): 2145-2149
Kastendieck, E.; Barthels, M. 1974: The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies Geburtshilfe und Frauenheilkunde 34(9): 758-762
Kudriashov, B.A.; Liapina, L.A.; Ul'ianov, A.M. 1978: Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin Voprosy Meditsinskoi Khimii 24(2): 255-260
Patrassi, G.M.; Toffanin, F.; Massa, G.; Schivazappa, L.; Girolami, A. 1979: Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state Folia Haematologica 106(3): 414-425
Stürner, K.H.; Holzhüter, H.; Ochs, H.G.; Angelkort, B.; Muchietti, F.; Wenzel, E. 1973: Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1328-1330
Moroi, M. 1982: Reactions of platelet membrane glycoprotein, glycocalicin, GPi and thrombin Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 50: 76-83
Princen, H.M.; Moshage, H.J.; Emeis, J.J.; de Haard, H.J.; Nieuwenhuizen, W.; Yap, S.H. 1985: Fibrinogen fragments X, Y, D and e increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats Thrombosis and Haemostasis 53(2): 212-215
Rübsamen, K.; Hornberger, W.; Kirchengast, M. 1995: Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857 Thrombosis and Haemostasis 74(5): 1353-1360
Brandriss, M.W. 1971: Evolution of delayed hypersensitivity reactions in man Journal of Immunology 107(6): 1771-1774
Sagua, H.; Schenone, H.; Knierim, F.; Vacarezza, R. 1972: Evolution of the immunological reactions in human trichinosis Boletin Chileno de Parasitologia 27(1): 58-60